Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Sell

Wall Street Data Solutions Rating

Sell

C

Acrivon Therapeutics, Inc. Common Stock (ACRV)

Pharmaceutical Preparations

https://www.acrivon.com

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Company matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

480 ARSENAL WAY, SUITE 100
WATERTOWN, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/15/2022

Market Cap

234,149,545

Shares Outstanding

22,190,000

Weighted SO

22,194,307

Total Employees

N/A

Upcoming Earnings

08/09/2024

Similar Tickers

AVTE --.--%

ADAG --.--%

RZLT --.--%

ANTX --.--%

ANEB --.--%

PMVP --.--%

MOLN --.--%

MLYS --.--%

ANAB --.--%

Beta

1.7013

Last Div

0.0000

Range

3.19-12.52

Chg

0.3300

Avg Vol

96893

Mkt Cap

234149545

Exch

NASDAQ

Country

US

Phone

617-207-8979

DCF Diff

5.8091

DCF

1.4209

Div Yield

0.0000

P/S

124.2832

EV Multiple

-2.5404

P/FV

1.2643

Div Yield %

0.0000

P/E

-3.9588

PEG

0.0384

Payout

0.0000

Current Ratio

16.1608

Quick Ratio

16.1608

Cash Ratio

4.0771

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

509.1427

CCC

-509.1427

Gross Margin

0.5202

Op Margin

-40.4963

Pretax Margin

-36.6253

Net Margin

-36.6253

Eff Tax Rate

-0.0263

ROA

-0.2992

ROE

-0.4731

ROCE

-0.3479

NI/EBT

1.0000

EBT/EBIT

0.9044

EBIT/Rev

-40.4963

Debt Ratio

0.0183

D/E

0.0195

LT Debt/Cap

0.0148

Total Debt/Cap

0.0192

Int Coverage

-46.6066

CF/Debt

-12.5937

Equity Multi

1.0672

Rec Turnover

0.0000

Pay Turnover

0.7169

Inv Turnover

0.0000

FA Turnover

0.2531

Asset Turnover

0.0082

OCF/Share

-1.4712

FCF/Share

-1.5294

Cash/Share

4.9965

OCF/Sales

-28.2155

FCF/OCF

1.0396

CF Coverage

-12.5937

ST Coverage

-54.3538

CapEx Coverage

-25.2772

Div&CapEx Cov

-25.2772

P/BV

1.2643

P/B

1.2643

P/S

124.2832

P/E

-3.9588

P/FCF

-4.2372

P/OCF

-5.1387

P/CF

-5.1387

PEG

0.0384

P/S

124.2832

EV Multiple

-2.5404

P/FV

1.2643

DPS

0.0000

Latest Headlines (EST)

MarketWatch Jan 06, 05:58 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

Revenue Product Segmentation